Pulmonx Corp. Announces 2024 Annual Meeting of Stockholders on May 16

TL;DR

Pulmonx Corporation is holding its 2024 Annual Meeting of Stockholders virtually on May 16, 2024, to elect directors, ratify auditors, and vote on executive compensation.

AI Summary

Pulmonx Corp (LUNG) filed a Proxy Statement (DEF 14A) with the SEC on April 5, 2024. Pulmonx Corporation will hold its 2024 Annual Meeting of Stockholders on May 16, 2024, at 8:00 a.m. Pacific Daylight Time. The meeting will be conducted exclusively via the Internet at www.virtualshareholdermeeting.com/LUNG2024. Stockholders will vote on the election of two Class I directors, Glendon E. French and Tiffany Sullivan, for terms until the 2027 Annual Meeting. The agenda includes ratifying BDO USA, LLP as the independent registered public accounting firm for fiscal year 2024. A non-binding advisory vote to approve the Company's executive compensation is also scheduled.

Why It Matters

For investors and stakeholders tracking Pulmonx Corp, this filing contains several important signals. This filing is a proxy statement (DEF 14A) detailing the agenda and proposals for the upcoming annual shareholder meeting, which is crucial for corporate governance and shareholder rights. The election of directors and ratification of the auditor are key decisions that impact the company's strategic direction and financial oversight.

Risk Assessment

Risk Level: low — Pulmonx Corp shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting and does not contain new financial performance data or significant strategic shifts, indicating a low level of immediate risk.

Analyst Insight

Stockholders should review the director nominees and executive compensation proposals before the May 16th meeting to exercise their voting rights effectively.

Key Numbers

• May 16, 2024 — Annual Meeting Date (Pulmonx Corporation's 2024 Annual Meeting of Stockholders)
• 8:00 a.m. Pacific Daylight Time — Meeting Time (Time of the 2024 Annual Meeting of Stockholders)
• March 20, 2024 — Record Date (Date for determining stockholders entitled to vote)
• 2027 — Director Term (Term for elected Class I directors)
• 2024 — Fiscal Year (Fiscal year for which BDO USA, LLP is proposed as auditor)

Key Players & Entities

• Pulmonx Corp (company) — Registrant
• Glendon E. French (person) — Director nominee
• Tiffany Sullivan (person) — Director nominee
• BDO USA, LLP (company) — Independent registered public accounting firm
• May 16, 2024 (date) — Annual Meeting date
• March 20, 2024 (date) — Record date for stockholders
• 2024 (date) — Fiscal year end
• 2027 (date) — Director term end

FAQ

Industry Context

Pulmonx Corporation operates in the medical device industry, specifically focusing on treatments for severe lung disease.

Regulatory Implications

This filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies from shareholders.

What Investors Should Do

1. Review the qualifications of director nominees Glendon E. French and Tiffany Sullivan.
2. Evaluate the proposal to ratify BDO USA, LLP as the independent auditor for fiscal year 2024.
3. Consider the non-binding advisory vote on executive compensation.

Key Dates

• 2024-05-16: Annual Meeting of Stockholders — Election of directors, ratification of auditor, advisory vote on executive compensation.
• 2024-03-20: Record Date — Determines stockholders eligible to vote at the Annual Meeting.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a definitive proxy statement, indicating it follows any preliminary filings and contains the final agenda for the annual shareholder meeting.

Filing Documents

• ny20025223x1_def14a.htm (DEF 14A) — 800KB
• ny20025223x1_linechart0x1.jpg (GRAPHIC) — 161KB
• ny20025223x1_pc1.jpg (GRAPHIC) — 599KB
• ny20025223x1_pc2.jpg (GRAPHIC) — 556KB
• 0001140361-24-018313.txt ( ) — 2614KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT ​ ​ 19 INFORMATION REGARDING EXECUTIVE OFFICERS ​ ​ 21

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION ​ ​ 22 EQUITY COMPENSATION PLAN INFORMATION ​ ​ 34 DIRECTOR COMPENSATION ​ ​ 35 TRANSACTIONS WITH RELATED PERSONS AND INDEMNIFICATION ​ ​ 38 STOCKHOLDER PROPOSALS FOR 2025 ANNUAL MEETING OF STOCKHOLDERS ​ ​ 40 HOUSEHOLDING OF PROXY MATERIALS ​ ​ 41 OTHER MATTERS ​ ​ 42 i TABLE OF CONTENTS PULMONX CORPORATION 700 Chesapeake Drive Redwood City, California 94063 (650) 364-0400 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS   May 16, 2024 QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING Why did I receive a notice regarding the availability of proxy materials on the internet? Pursuant to rules adopted by the Securities and Exchange Commission (the “SEC”), we have elected to provide access to our proxy materials over the Internet. Accordingly, we have sent you a Notice of Internet Availability of Proxy Materials (the “Notice”) because the Board of Directors (sometimes referred to as the “Board”) of Pulmonx Corporation (referred to herein as “Pulmonx,” the “Company,” “we,” “our” or “us”) is soliciting your proxy to vote at the 2024 Annual Meeting of Stockholders (the “Annual Meeting”), including at any adjournments or postponements of the Annual Meeting. All stockholders will have the ability to access the proxy materials on the website referred to in the Notice or request to receive a printed set of the proxy materials. Instructions on how to access the proxy materials over the Internet or to request a printed copy may be found in the Notice. On or about April 5, 2024, we expect to mail to our stockholders the Notice containing instructions on how to access this proxy statement for the Annual Meeting (the “Proxy Statement”) and our Annual Repo

View Full Filing

View this DEF 14A filing on SEC EDGAR